People in midlife face a care system that frequently fails to recognise, name, or treat hormonal symptoms. An estimated 84% in primary care do not seek treatment for menopause (Kapoor et al., 2025), yet the reasoning behind this gap (e.g., patients’ beliefs, pathways, and vocabulary) remains poorly understood. Surveys identify what patients do; they do not always reveal why.

Organic patient narrative data, analysed through established qualitative behavioural frameworks, produces insights that surveys cannot reach. A $600bn+ women’s health market requires capital directed at real patient pathways, not assumptions. Unsolicited patient voice, at scale, is where investors and operators learn where those pathways are, what is blocking them, and how to deliver value.